{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:28:36Z","timestamp":1793125716828,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012331","name":"Agentschap Innoveren en Ondernemen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.chroma.2026.467219","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T23:47:00Z","timestamp":1782431220000},"page":"467219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Impurity profiling of lipid-conjugated oligonucleotides using reversed-phase with and without ion-pair reagents and hydrophilic interaction liquid chromatography"],"prefix":"10.1016","volume":"1784","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4807-727X","authenticated-orcid":false,"given":"Quang-Dong","family":"Bui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Kesselaers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Noten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8928-5983","authenticated-orcid":false,"given":"Tiny","family":"Deschrijver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5465-0127","authenticated-orcid":false,"given":"Sebastiaan","family":"Eeltink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chroma.2026.467219_bib0001","series-title":"Specification Drug Substance and Product","first-page":"789","article-title":"Oligonucleotides","author":"Ford","year":"2025"},{"key":"10.1016\/j.chroma.2026.467219_bib0002","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/hum.2015.070","article-title":"Oligonucleotide therapies: the past and the present, hum","volume":"26","author":"Lundin","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.chroma.2026.467219_bib0003","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/nar\/gkad067","article-title":"Chemistry, structure and function of approved oligonucleotide therapeutics","volume":"51","author":"Egli","year":"2023","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.chroma.2026.467219_bib0004","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/nar\/gky1232","article-title":"Hydrophobicity drives the systemic distribution of lipid-conjugated siRNAs via lipid transport pathways","volume":"47","author":"Osborn","year":"2019","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.chroma.2026.467219_bib0005","unstructured":"J.K. Nair, M. Maier, V. Jadhav, S. Milstein, K. Brown, R.G. Parmar, K.G. Rajeev, M. Manoharan, A.V. Kel\u2019in, M. Jayaraman, K. Charisse, A. Castoreno, C.S. Theile, K. Fitzgerald, Extrahepatic delivery, WO2019217459A1, n.d. https:\/\/patents.google.com\/patent\/US12397013B2\/en."},{"key":"10.1016\/j.chroma.2026.467219_bib0006","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1749-6632.1992.tb21095.x","article-title":"Chemical modifications to improve uptake and bioavailability of antisense oligonucleotides","volume":"660","author":"Manoharan","year":"1992","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.chroma.2026.467219_bib0007","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/nsr\/nwaa161","article-title":"Lipid\u2013oligonucleotide conjugates for bioapplications","volume":"7","author":"Li","year":"2020","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.chroma.2026.467219_bib0008","doi-asserted-by":"crossref","first-page":"6029","DOI":"10.1093\/nar\/gkz354","article-title":"Fatty acid conjugation enhances potency of antisense oligonucleotides in muscle","volume":"47","author":"Prakash","year":"2019","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.chroma.2026.467219_bib0009","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3390\/pharmaceutics14020342","article-title":"Delivery of oligonucleotides: efficiency with lipid conjugation and clinical outcome","volume":"14","author":"Tran","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.chroma.2026.467219_bib0010","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.1038\/sj.onc.1208760","article-title":"Lipid modification of GRN163, an N3\u2032 \u2192 P5\u2032 thio-phosphoramidate oligonucleotide, enhances the potency of telomerase inhibition","volume":"24","author":"Herbert","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.chroma.2026.467219_bib0011","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chroma.2026.467219_bib0012","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.2217\/fon-2022-0235","article-title":"Imetelstat in intermediate-2 or high-risk myelofibrosis refractory to JAK inhibitor: IMpactMF phase III study design","volume":"18","author":"Mascarenhas","year":"2022","journal-title":"Futur. Oncol."},{"key":"10.1016\/j.chroma.2026.467219_bib0013","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/cbdv.201000274","article-title":"Synthesis of lipid\u2013Oligonucleotide conjugates for RNA interference studies","volume":"8","author":"Grijalvo","year":"2011","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.chroma.2026.467219_bib0014","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mas.21615","article-title":"Therapeutic oligonucleotides, impurities, degradants, and their characterization by mass spectrometry","volume":"40","author":"Pourshahian","year":"2021","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.chroma.2026.467219_bib0015","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s00216-012-5935-5","article-title":"The analysis of major impurities of lipophilic-conjugated phosphorothioate oligonucleotides by ion-pair reversed-phase HPLC combined with MALDI-TOF-MS","volume":"403","author":"Liu","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.chroma.2026.467219_bib0016","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4088","article-title":"Chromatographic approaches for the characterization and quality control of therapeutic oligonucleotide impurities","volume":"32","author":"El Zahar","year":"2018","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.chroma.2026.467219_bib0017","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0021-9673(02)01812-5","article-title":"Comparison of peak shapes obtained with volatile (mass spectrometry-compatible) buffers and conventional buffers in reversed-phase high-performance liquid chromatography of bases on particulate and monolithic columns","volume":"987","author":"McCalley","year":"2003","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467219_bib0018","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00216-019-02236-9","article-title":"Analytical and preparative separation of phosphorothioated oligonucleotides: columns and ion-pair reagents","volume":"412","author":"Enmark","year":"2020","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.chroma.2026.467219_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2024.117758","article-title":"Recent advances and current challenges in hydrophilic interaction chromatography for the analysis of therapeutic oligonucleotides","volume":"176","author":"Lardeux","year":"2024","journal-title":"Trends Anal. Chem."},{"key":"10.1016\/j.chroma.2026.467219_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.464793","article-title":"Optimization of elution conditions and comparison of emerging biocompatible columns on the resolving power and detection sensitivity of oligonucleotides by ion-pairing reversed-phase liquid chromatography mass spectrometry","volume":"1720","author":"Bui","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467219_bib0021","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1021\/jasms.4c00270","article-title":"Overcoming challenges in oligonucleotide therapeutics analysis: a novel nonion pair approach","volume":"35","author":"Hayashi","year":"2024","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.chroma.2026.467219_bib0022","series-title":"Advanced Chromatography","first-page":"115","article-title":"The linear-solvent-strength model of gradient elution","author":"Snyder","year":"2021"},{"key":"10.1016\/j.chroma.2026.467219_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.465523","article-title":"Understanding the fundamentals of the on-off retention mechanism of oligonucleotides and their application to high throughput analysis","volume":"1739","author":"Lardeux","year":"2025","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467219_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2026.467085","article-title":"Ion-pair-free reversed-phase liquid chromatographic profiling of oligonucleotides through selective phosphorothioate alkylation","volume":"1781","author":"Bui","year":"2026","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467219_bib0025","unstructured":"Marija Prhavc, Y. Jin, M. Ramaseshan, Lipid monomers for therapeutic delivery of RNA, WO2023175536A1, n.d. https:\/\/patents.google.com\/patent\/WO2023175536A1\/ko."},{"key":"10.1016\/j.chroma.2026.467219_bib0026","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13321-018-0258-y","article-title":"Mordred: a molecular descriptor calculator","volume":"10","author":"Moriwaki","year":"2018","journal-title":"J. Cheminformat."},{"key":"10.1016\/j.chroma.2026.467219_bib0027","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.chroma.2005.07.029","article-title":"Determination of lipophilicity by reversed-phase high-performance liquid chromatography","volume":"1091","author":"Liu","year":"2005","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467219_bib0028","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.3390\/molecules24173187","article-title":"Comparison of the utility of RP-TLC technique and different computational methods to assess the lipophilicity of selected antiparasitic, antihypertensive, and anti-inflammatory drugs","volume":"24","author":"Pyka-Paj\u0105k","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.chroma.2026.467219_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.465285","article-title":"Impact of mobile and stationary phases on siRNA duplex stability in liquid chromatography","volume":"1733","author":"Gilar","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467219_bib0030","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.xphs.2024.12.009","article-title":"Why a complementary analytical toolbox is essential for correct siRNA duplex content determination","volume":"114","author":"Carloni","year":"2025","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.chroma.2026.467219_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.465074","article-title":"Impact of ion-pairing systems choice on diastereomeric selectivity of phosphorothioated oligonucleotides in reversed-phase liquid chromatography","volume":"1730","author":"Vos\u00e1hlov\u00e1","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467219_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2025.466308","article-title":"Emerging trends in the characterization of oligonucleotide diastereomers","volume":"1761","author":"Goyon","year":"2025","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467219_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2025.466639","article-title":"Decoding diastereomeric and impurity profiles of phosphorothioated siRNAs via 2D anion-exchange chromatography coupled with ion-pair reversed phase liquid chromatography mass spectrometry","volume":"1768","author":"Bui","year":"2026","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467219_bib0034","first-page":"eabg9065","article-title":"Per- and polyfluoroalkyl substances in the environment","volume":"375","author":"Evich","year":"2022","journal-title":"Science (1979)"}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967326005480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967326005480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:40:05Z","timestamp":1785901205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021967326005480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":34,"alternative-id":["S0021967326005480"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2026.467219","relation":{},"ISSN":["0021-9673"],"issn-type":[{"value":"0021-9673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impurity profiling of lipid-conjugated oligonucleotides using reversed-phase with and without ion-pair reagents and hydrophilic interaction liquid chromatography","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2026.467219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"467219"}}